Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-014328
Filing Date
2018-08-02
Accepted
2018-08-02 17:19:03
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20180630_10q.htm 10-Q 1094205
2 EXHIBIT 31.1 ex_119016.htm EX-31.1 8778
3 EXHIBIT 31.2 ex_119017.htm EX-31.2 8798
4 EXHIBIT 32.1 ex_119018.htm EX-32.1 6903
  Complete submission text file 0001437749-18-014328.txt   4204308

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acrx-20180630.xml EX-101.INS 798604
6 XBRL TAXONOMY EXTENSION SCHEMA acrx-20180630.xsd EX-101.SCH 51010
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20180630_cal.xml EX-101.CAL 34538
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20180630_def.xml EX-101.DEF 271887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20180630_lab.xml EX-101.LAB 230154
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20180630_pre.xml EX-101.PRE 293377
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 18989533
SIC: 2834 Pharmaceutical Preparations